Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 34 min ago

Yarrow Bioscience, Inc.: Logos Global Management LP amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 17 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Logos Global Management LP amended its Schedule 13G filing on Yarrow Bioscience, Inc., disclosing a change to its passive stake in the company under SEC accession 0000935836-26-000626. The amendment updates the investment firm's previously reported beneficial ownership position in the bioscience company. Schedule 13G filings are required of investors holding more than 5% of a company's shares who do not seek control, making the revision a signal of shifting institutional ownership. The filing did not disclose a change in control intent, and investors will watch for further 13G or 13D amendments to gauge whether Logos continues to adjust its position.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Logos Global Management LP, Yarrow Bioscience, Inc.